Published in Eur Respir J on November 01, 1992
Regulation by phosphodiesterase isoenzymes of non-adrenergic non-cholinergic contraction in guinea-pig isolated main bronchus. Br J Pharmacol (1995) 0.86
Effects of theophylline and rolipram on antigen-induced airway responses in neonatally immunized rabbits. Br J Pharmacol (1996) 0.81
Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit. J Pediatr Pharmacol Ther (2013) 0.78
What role for theophylline? Thorax (1994) 0.77
Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine. Am Rev Respir Dis (1981) 3.00
Effect of theophylline on gastroesophageal reflux in patients with asthma. J Allergy Clin Immunol (1988) 2.13
Structural and functional domains of the Drosophila ncd microtubule motor protein. J Biol Chem (1993) 2.06
Crystal structure of the N-terminal domain of MukB: a protein involved in chromosome partitioning. Structure (1999) 2.04
Weak and strong states of kinesin and ncd. J Mol Biol (1996) 1.89
Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75
Three-dimensional cryoelectron microscopy of dimeric kinesin and ncd motor domains on microtubules. Proc Natl Acad Sci U S A (1996) 1.71
Nucleotide-dependent angular change in kinesin motor domain bound to tubulin. Nature (1995) 1.57
Improvement in exercise performance by inhalation of methoxamine in patients with impaired left ventricular function. N Engl J Med (1992) 1.55
Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med (1989) 1.50
Do nasal mast cells release histamine on stimulation with substance P in allergic rhinitis? Clin Exp Allergy (1994) 1.42
Kinetic evidence for low chemical processivity in ncd and Eg5. J Mol Biol (1997) 1.39
Right ventricular involvement in obstructive cardiomyopathies: haemodynamic studies in 13 cases. Br Heart J (1966) 1.38
Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: a statistical approach. Eur Respir J (1989) 1.27
EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-- descriptive characteristics. Clin Exp Allergy (1999) 1.23
Neurogenic mechanisms in bronchial inflammatory diseases. Allergy (2004) 1.22
Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med (1981) 1.21
Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues. Am J Respir Crit Care Med (1997) 1.21
Microtubule minus ends can be labelled with a phage display antibody specific to alpha-tubulin. J Mol Biol (1996) 1.21
The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol Ther (2007) 1.16
Arachidonic acid metabolites and airway epithelium-dependent relaxant factor. J Pharmacol Exp Ther (1987) 1.13
Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am J Respir Cell Mol Biol (1996) 1.09
The relationship between use of the maximum tolerated dose and study sensitivity for detecting rodent carcinogenicity. Fundam Appl Toxicol (1994) 1.08
Sodium-potassium ATPase, calcium, and immunological histamine release. Biochem Pharmacol (1983) 1.07
Nasal mucociliary transport in healthy subjects is slower when breathing dry air. Eur Respir J (1988) 1.06
Chronobiological study of the relationship between dyspnoea and airway obstruction in symptomatic asthmatic subjects. Clin Sci (Lond) (1989) 1.06
Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int (2001) 1.03
The mandibular canal of the edentulous jaw. Clin Anat (2001) 1.02
Epithelial modulation of tracheal smooth muscle response to antigenic stimulation. J Appl Physiol (1985) (1986) 1.01
Sodium-potassium ATPase inhibition potentiates compound 48/80-induced histamine secretion from mast cells. Br J Pharmacol (1984) 1.01
Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy (2004) 1.00
Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br J Pharmacol (1981) 1.00
HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med (1994) 0.99
Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol (2001) 0.99
Acute effects of intratracheal administration of platelet-activating factor in baboons. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.97
Inhaled substance P induces activation of alveolar macrophages and increases airway responses in the guinea-pig. Neuropeptides (1993) 0.95
Altitude and the human pulmonary circulation. Clin Sci (Lond) (1981) 0.93
Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J (2002) 0.93
Is arterialized earlobe blood PO2 an acceptable substitute for arterial blood PO2? Eur Respir J (1996) 0.93
Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis (1991) 0.92
Human bronchial smooth muscle cells in culture produce stem cell factor. Eur Respir J (1999) 0.92
Three-dimensional cryoelectron microscopy of 16-protofilament microtubules: structure, polarity, and interaction with motor proteins. J Struct Biol (1997) 0.92
New insights into the second generation antihistamines. Drugs (2001) 0.91
A single-compartment model cannot describe passive expiration in intubated, paralysed humans. Eur Respir J (1991) 0.91
Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction. Mol Pharmacol (1988) 0.89
Exhaled nitric oxide during acute changes of airways calibre in asthma. Eur Respir J (1996) 0.88
Elevated pulmonary artery wedge pressure at rest and during exercise in chronic bronchitis: fact or fancy. Clin Sci (1969) 0.88
Calcium dependent modulation of histamine release from mast cells by sodium and potassium. Agents Actions (1985) 0.88
Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons. Agents Actions (1981) 0.87
[The bronchorelaxant effect of helicidine, a Helix pomatia extract, interferes with prostaglandin E2]. Pathol Biol (Paris) (1999) 0.87
Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2. J Pharmacol Exp Ther (1992) 0.87
Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions. Eur Respir J (2002) 0.87
The effect of intravenous phenylephrine on airway calibre in asthma. Eur Respir J (1995) 0.86
Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7. Clin Exp Allergy (1996) 0.86
Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture. Mol Pharmacol (1998) 0.86
Pretreatment with an inhaled alpha 1-adrenergic agonist, methoxamine, reduces exercise-induced asthma. Eur Respir J (1989) 0.86
Effects of isoproterenol on the pulmonary circulation in obstructive airways disease. Clin Sci (1967) 0.86
Locally deposited but not inhaled frusemide reduces nasal potential difference in healthy subjects. Eur J Clin Pharmacol (1993) 0.86
In vitro bronchial hyperresponsiveness after lung transplantation in the rat. Am J Physiol (1992) 0.86
Breathing dry air causes acute epithelial damage and inflammation of the guinea pig trachea. J Appl Physiol (1985) (1988) 0.85
Evidence for in vitro expression of B1 receptor in the mouse trachea and urinary bladder. Br J Pharmacol (1999) 0.85
Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy (2001) 0.85
Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur Respir J (2001) 0.85
Serum eosinophil cationic protein measurements in the management of perennial and periodic asthma: a prospective study. Eur Respir J (1998) 0.84
Pressure-flow-volume relationships in pulmonary circulation of normal highlanders. J Appl Physiol (1976) 0.84
Evaluation of cytotoxicity of new semi-fluorinated amphiphiles derived from dimorpholinophosphate. Biomaterials (2003) 0.84
Variability of the pulmonary vascular response to acute hypoxia in chronic bronchitis. Chest (1988) 0.84
Protein design on computers. Five new proteins: Shpilka, Grendel, Fingerclasp, Leather, and Aida. Proteins (1992) 0.84
Effects of exercise and postural changes on pulmonary haemodynamics in patients with chronic lung diseases. Scand J Respir Dis Suppl (1971) 0.83
Nasal response to substance P and methacholine in subjects with and without allergic rhinitis. Eur Respir J (1988) 0.83
Pulmonary arterial hypertension in portal hypertension. Clin Gastroenterol (1985) 0.82
Local cellular and humoral responses to antigenic and distilled water challenge in subjects with allergic rhinitis. Am Rev Respir Dis (1988) 0.82
Modelling of passive expiration in patients with adult respiratory distress syndrome. Eur Respir J (1993) 0.82
Effect of glucocorticoids on stem cell factor expression in human asthmatic bronchi. Clin Exp Allergy (2006) 0.81
Exercise- and hyperventilation-induced asthma. Bull Eur Physiopathol Respir (1985) 0.81
Repeated inhalation of low doses of cat allergen that do not induce clinical symptoms increases bronchial hyperresponsiveness and eosinophil cationic protein levels. Int Arch Allergy Immunol (1999) 0.81
Relationship between spontaneous dyspnoea and lability of airway obstruction in asthma. Clin Sci (Lond) (1992) 0.81
Activation of the lung S1P(1) receptor reduces allergen-induced plasma leakage in mice. Br J Pharmacol (2009) 0.81
Causes of error of respiratory pressure-volume curves in paralyzed subjects. J Appl Physiol (1985) (1988) 0.81
Designing meaningful industry metrics for clinical productivity for anesthesiology departments. Anesth Analg (2001) 0.81
Passive partitioning of respiratory volumes and time constants in ventilated patients. Eur Respir J (1992) 0.80
Association of PEEP with two different inflation volumes in ARDS patients: effects on passive lung deflation and alveolar recruitment. Intensive Care Med (2000) 0.80
[Maximal ventilatory pressure through the mouth in adults: normal values and explanatory variables]. Rev Mal Respir (1991) 0.80
Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity. Eur J Clin Pharmacol (1999) 0.80
Nerve growth factor secretion by human lung epithelial A549 cells in pro- and anti-inflammatory conditions. Eur J Pharmacol (2001) 0.80
Comparison of effects of fentanyl and alfentanil on intra-ocular pressure. A double-blind controlled trial. Anaesthesia (1986) 0.80
Effects of sitting up on pulmonary blood pressure, flow, and volume in man. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.80
Haemodynamic effects of propranolol in chronic lung diseases. Clin Sci (1967) 0.80
Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis. Eur Respir J (1996) 0.80
Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy (1995) 0.80
Effects of clonidine on bronchial responses to histamine in normal and asthmatic subjects. Eur Respir J (1988) 0.79
Circulatory transport of oxygen in patients with chronic airflow obstruction exercising maximally. Am Rev Respir Dis (1982) 0.79
Vascular factors in bronchial hyperresponsiveness and asthma. Respir Med (1992) 0.79
Adenosine reduces airway excitatory non-cholinergic (e-NC) contraction through both A1 and A2 adenosine receptor activation in the guinea pig. Fundam Clin Pharmacol (1997) 0.79
Effect of furosemide on prostaglandin synthesis by human nasal and bronchial epithelial cells in culture. Am J Respir Cell Mol Biol (1994) 0.79
Effects of nifedipine on responses to exercise in normal subjects. J Appl Physiol (1985) (1985) 0.78
Analysis of hsp70 gene polymorphism in allergic asthma. Allergy (1999) 0.78
Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis. Br J Clin Pharmacol (1992) 0.78